title: HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.
abstract: Little is known of the role of classical HLA-A and -B class I alleles in determining resistance, susceptibility, or the severity of acute viral infections. Appropriate paradigms for immunogenetic studies of acute viral infections are dengue fever (DF) and dengue hemorrhagic fever (DHF). Both primary and secondary infections with dengue virus (DEN) serotypes 1, 2, 3 or 4, can result in either clinically less severe DF or the more severe DHF. In secondary exposures, a memory response is induced in immunologically primed individuals, which can both clear the infecting dengue virus and contribute to its pathology. In a case-control study of 263 ethnic Thai patients infected with either DEN-1, -2, -3 or -4, we detected HLA class I associations with secondary infections, but not in immunologically naive patients with primary infections. HLA-A*0203 was associated with the less severe DF, regardless of the secondary infecting virus serotype. By contrast, HLA-A*0207 was associated with susceptibility to the more severe DHF in patients with secondary DEN-1 and DEN-2 infections only. Conversely, HLA-B*51 was associated with the development of DHF in patients with secondary infections, and HLA-B*52 was associated with DF in patients with secondary DEN-1 and DEN-2 infections. Moreover, HLA-B44, B62, B76 and B77 also appeared to be protective against developing clinical disease after secondary dengue virus infection. These results confirm that classical HLA class I alleles are associated with the clinical outcome of exposure to dengue virus, in previously exposed and immunologically primed individuals.
authors.affiliation: Institute of Urology and Nephrology, University College, London, UK. h.stephens@ucl.ac.uk
authors.forename: H A F
authors.initials: HA
authors.lastname: Stephens
authors.forename: R
authors.initials: R
authors.lastname: Klaythong
authors.forename: M
authors.initials: M
authors.lastname: Sirikong
authors.forename: D W
authors.initials: DW
authors.lastname: Vaughn
authors.forename: S
authors.initials: S
authors.lastname: Green
authors.forename: S
authors.initials: S
authors.lastname: Kalayanarooj
authors.forename: T P
authors.initials: TP
authors.lastname: Endy
authors.forename: D H
authors.initials: DH
authors.lastname: Libraty
authors.forename: A
authors.initials: A
authors.lastname: Nisalak
authors.forename: B L
authors.initials: BL
authors.lastname: Innis
authors.forename: A L
authors.initials: AL
authors.lastname: Rothman
authors.forename: F A
authors.initials: FA
authors.lastname: Ennis
authors.forename: D
authors.initials: D
authors.lastname: Chandanayingyong
mesh_terms: D000293:Adolescent; D000483:Alleles; D002675:Child, Preschool; D003715:Dengue / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D003716:Dengue Virus / Q000145:classification*; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D015234:HLA-A Antigens / Q000145:classification / Q000235:genetics*; D015789:HLA-A2 Antigen / Q000235:genetics; D015235:HLA-B Antigens / Q000145:classification / Q000235:genetics*; D059949:HLA-B51 Antigen; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods; D012703:Serotyping; D019595:Severe Dengue / Q000453:epidemiology; D013785:Thailand / Q000453:epidemiology
chemical_list: D015234:HLA-A Antigens; D015789:HLA-A2 Antigen; D015235:HLA-B Antigens; D059949:HLA-B51 Antigen